Literature DB >> 3593608

The in vitro behavior of fetal condylar cartilage in serum-free hormone-supplemented medium.

M Silbermann, H Tenenbaum, E Livne, R Leapman, K von der Mark, A H Reddi.   

Abstract

Mandibular condyles of fetal mice 19-20 days in utero were kept in a serum-free organ culture system for up to 14 days and were investigated for their capacity to develop osteoid and to mineralize in vitro. After 3 days in culture, the cartilage of the mandibular condyle appeared to have maintained all its inherent structural characteristics, including its various cell layers: chondroprogenitor, chondroblastic, and hypertrophic. After 7-9 days in culture, no chondroblasts could be seen; instead, most of the cartilage consisted of hypertrophic chondrocytes. In addition, various areas throughout the explant revealed the appearance of osteoidlike material. The process of matrix mineralization progressed with time, and by the 14th day new bonelike material was found to occupy a larger portion of the explant. The newly formed matrix reacted positively with antibodies against type I and type III collagens, as well as against bone alkaline phosphatase. Electron microscopic examination showed that the mineralization appeared to be associated with collagen fibers as well as the matrix vesicles. In composition, the in vitro-formed mineral deposits resembled hydroxyapatite crystals. Biochemical assays indicated that the newly formed tissue reacted strongly for alkaline phosphatase and incorporated 45Ca. The findings of the present study imply that fetal condylar cartilage possesses the potential to develop in vitro osseouslike tissue even in a system that is serum-free. Due to the fact that the newly formed extracellular matrix mineralized and reacted positively to bone markers as well as to cartilage macromolecules, it would seem justifiable to define the new tissue as chondroid bone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593608     DOI: 10.1016/8756-3282(87)90080-9

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Media for cultivation of animal cells: an overview.

Authors:  A Mizrahi; A Lazar
Journal:  Cytotechnology       Date:  1988-07       Impact factor: 2.058

2.  Effects of leukemogenic retroviruses on condylar cartilage in vitro: an ultrastructural study.

Authors:  E Livne; J Schmidt; E I Closs; M Silbermann; V Erfle
Journal:  Calcif Tissue Int       Date:  1989-01       Impact factor: 4.333

3.  In vitro response of neonatal condylar cartilage to simultaneous exposure to the parathyroid hormone fragments 1-34, 28-48, and 53-84 hPTH.

Authors:  M Silbermann; R Shurtz-Swirski; D Lewinson; P Shenzer; H Mayer
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

4.  In vitro induction of osteosarcomalike lesion by transformation of differentiating skeletal precursor cells with FBR murine osteosarcoma virus.

Authors:  M Silbermann; J Schmidt; E Livne; K von der Mark; V Erfle
Journal:  Calcif Tissue Int       Date:  1987-10       Impact factor: 4.333

5.  Structural changes in condylar cartilage following prolonged exposure to the human parathyroid hormone fragment (hPTH) 1-34 in vitro.

Authors:  D Lewinson; R Shurtz-Swirski; P Shenzer; E Wingender; H Mayer; M Silbermann
Journal:  Cell Tissue Res       Date:  1992-05       Impact factor: 5.249

6.  Effects of different concentrations of serum on cartilage growth in an organ culture system.

Authors:  R Shurtz-Swirski; D Lewinson; P Shenzer; M Silbermann
Journal:  In Vitro Cell Dev Biol       Date:  1989-11

7.  In vitro formation of mineralized cartilagenous tissue by articular chondrocytes.

Authors:  R A Kandel; J Boyle; G Gibson; T Cruz; M Speagle
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416

8.  Insulin enhances the growth of cartilage in organ and tissue cultures of mouse neonatal mandibular condyle.

Authors:  G Maor; M Silbermann; K von der Mark; D Heingard; Z Laron
Journal:  Calcif Tissue Int       Date:  1993-04       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.